Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyInfectious diseasePulmonology Open Access | 10.1172/jci.insight.198551

Long-term reprogramming of classical monocytes with altered ontogeny mediates enhanced lung injury in sepsis survivors

Scott J. Denstaedt,1 Breanna McBean,2 Alan P. Boyle,2 Brett C. Arenberg,1 Matthias Mack,3 Bethany B. Moore,1 Michael W. Newstead,1 Yamei Deng,4 Alexey I. Nesvizhskii,4 Benjamin H. Singer,1 Jennifer Cano,5 Hallie C. Prescott,1 Helen S. Goodridge,6 and Rachel L. Zemans1

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Denstaedt, S. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by McBean, B. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Boyle, A. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Arenberg, B. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Mack, M. in: PubMed | Google Scholar |

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Moore, B. in: PubMed | Google Scholar |

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Newstead, M. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Deng, Y. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Nesvizhskii, A. in: PubMed | Google Scholar |

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Singer, B. in: PubMed | Google Scholar |

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Cano, J. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Prescott, H. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Goodridge, H. in: PubMed | Google Scholar

1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America

2Human Genetics, University of Michigan, Ann Arbor, United States of America

3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany

4Department of Pathology, University of Michigan, Ann Arbor, United States of America

5VA Center for Clinical Management Research, Ann Arbor, United States of America

6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America

Find articles by Zemans, R. in: PubMed | Google Scholar |

Published September 24, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.198551.
Copyright © 2026, Denstaedt et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published September 24, 2026 - Version history
View PDF
Abstract

Patients who survive sepsis are predisposed to new hospitalizations for respiratory failure, but the underlying mechanisms are unknown. Using a murine model in which prior sepsis predisposes to enhanced lung injury, we previously discovered that classical monocytes persist in the lungs after long-term recovery from sepsis and exhibit enhanced cytokine expression after secondary challenge with intra-nasal lipopolysaccharide. Here, we hypothesized that immune reprogramming of post-sepsis monocytes and altered ontogeny predispose to enhanced lung injury. Monocyte depletion and/or adoptive transfer was performed three weeks and three months after sepsis. Monocytes from post-sepsis mice were necessary and sufficient for enhanced LPS-induced lung injury and promoted neutrophil degranulation. Prior sepsis enhanced JAK-STAT signaling and AP-1 accessibility in monocytes and shifted monocytes toward the neutrophil-like monocyte lineage. Neutrophil-like monocytes demonstrated a pro-inflammatory phenotype with enhanced IL-1β expression and reduced phagocytic capacity. In human sepsis and/or pneumonia survivors, monocytes were predictive of 90-day mortality and exhibit transcriptional and proteomic neutrophil-like signatures. We conclude that sepsis reprograms monocytes into a pro-inflammatory phenotype and skews bone marrow progenitors and monocytes toward the neutrophil-like lineage, predisposing them to induce neutrophil degranulation and lung injury.

Graphical Abstract
graphical abstract
Supplemental material

View Genomic Data Supplement

View

Version history
  • Version 1 (September 24, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts